[Editor's note: A version of this article appeared previously in our sister publication, Pink Sheet.]
The US Food and Drug Administration may be headed for a second straight year of cuts to its non-user fee...
US FDA May See Second Straight Year of Non-User Fee Funding Cuts From Congress
The House Appropriations Agriculture, Rural Development, and FDA Subcommittee advanced the FDA’s fiscal year 2025 funding bill, beginning a likely long and difficult budget cycle.
